News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
26,005 Results
Type
Article (1118)
Company Profile (3)
Press Release (24884)
Section
Business (12869)
Career Advice (78)
Deals (1670)
Drug Delivery (2)
Drug Development (2133)
Employer Resources (1)
FDA (405)
Job Trends (542)
News (16343)
Policy (657)
Tag
Academia (27)
Accelerated approval (2)
Allergies (4)
Alliances (872)
ALS (5)
Alzheimer's disease (28)
Antibody-drug conjugate (ADC) (8)
Approvals (426)
Artificial intelligence (7)
Autoimmune disease (4)
Automation (2)
Bankruptcy (7)
Best Places to Work (472)
BIOSECURE Act (1)
Biosimilars (4)
Biotechnology (2)
Bladder cancer (7)
Brain cancer (1)
Breast cancer (28)
Cancer (158)
Cardiovascular disease (11)
Career advice (69)
Career pathing (1)
CAR-T (15)
Cell therapy (24)
Cervical cancer (1)
Clinical research (2001)
Collaboration (15)
Compensation (26)
Complete response letters (3)
COVID-19 (59)
C-suite (5)
Cystic fibrosis (3)
Data (268)
Depression (5)
Dermatology (5)
Diabetes (9)
Diagnostics (238)
Digital health (3)
Diversity, equity & inclusion (1)
Drug discovery (6)
Drug pricing (1)
Duchenne muscular dystrophy (5)
Earnings (12674)
Editorial (1)
Employer resources (1)
Events (2088)
Executive appointments (4)
FDA (625)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (3)
Funding (18)
Gene editing (2)
Generative AI (1)
Gene therapy (16)
GLP-1 (19)
Government (54)
Guidances (138)
Healthcare (577)
HIV (1)
Huntington's disease (2)
IgA nephropathy (2)
Immunology and inflammation (5)
Indications (3)
Infectious disease (66)
Inflammatory bowel disease (4)
Influenza (4)
Intellectual property (3)
Interviews (31)
IPO (1237)
Job creations (102)
Job search strategy (39)
Kidney cancer (1)
Labor market (3)
Layoffs (4)
Leadership (1)
Legal (111)
Liver cancer (6)
Lung cancer (16)
Lymphoma (23)
Machine learning (1)
Manufacturing (13)
MASH (35)
Medical device (612)
Medtech (617)
Mergers & acquisitions (449)
Metabolic disorders (54)
Multiple sclerosis (4)
NASH (4)
Neurodegenerative disease (9)
Neuropsychiatric disorders (4)
Neuroscience (69)
NextGen: Class of 2026 (116)
Non-profit (36)
Now hiring (2)
Obesity (11)
Opinion (5)
Ovarian cancer (9)
Pain (1)
Pancreatic cancer (4)
Parkinson's disease (6)
Patents (5)
Patient recruitment (14)
Peanut (2)
People (689)
Pharmacy benefit managers (2)
Phase 1 (484)
Phase 2 (820)
Phase 3 (829)
Pipeline (671)
Policy (1)
Postmarket research (73)
Preclinical (188)
Press Release (1)
Prostate cancer (5)
Radiopharmaceuticals (9)
Rare diseases (17)
Real estate (105)
Regulatory (593)
Reports (2)
Research institute (32)
Resumes & cover letters (9)
Rett syndrome (2)
RNA editing (1)
RSV (3)
Schizophrenia (7)
Series A (2)
Series B (3)
Sponsored (1)
Startups (42)
Supply chain (1)
Vaccines (21)
Venture capital (3)
Weight loss (2)
Women's health (3)
Worklife (1)
Date
Last 7 days (21)
Last 30 days (114)
Last 365 days (1423)
2026 (349)
2025 (1481)
2024 (1681)
2023 (1869)
2022 (2080)
2021 (2042)
2020 (1795)
2019 (1154)
2018 (961)
2017 (885)
2016 (516)
2015 (817)
2014 (485)
2013 (242)
2012 (333)
2011 (6664)
2010 (409)
Location
Africa (12)
Alabama (1)
Arizona (6)
Asia (1580)
Australia (174)
California (590)
Canada (150)
China (51)
Colorado (29)
Connecticut (17)
Delaware (32)
Europe (3641)
Florida (70)
Georgia (27)
Illinois (44)
India (2)
Indiana (36)
Japan (13)
Kansas (5)
Kentucky (4)
Louisiana (8)
Maine (3)
Maryland (104)
Massachusetts (369)
Michigan (17)
Minnesota (60)
Missouri (4)
Montana (1)
Nevada (3)
New Hampshire (6)
New Jersey (193)
New York (179)
North Carolina (65)
Northern California (274)
Ohio (14)
Pennsylvania (127)
Rhode Island (2)
South America (37)
South Carolina (1)
Southern California (281)
Tennessee (7)
Texas (72)
United States (2119)
Utah (26)
Virginia (4)
Washington D.C. (1)
Washington State (34)
Wisconsin (5)
26,005 Results for "128".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Innovent Announces First Participant Dosed of IBI128 (Tigulixostat, XOI) in Phase 3 Clinical Study
March 23, 2026
·
7 min read
Press Releases
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
February 5, 2026
·
6 min read
Press Releases
CAR T-Cell Therapy Market Size Worth USD 128.55 Billion by 2034
July 22, 2025
·
1 min read
Press Releases
Innovent Announces Phase 2 Results of Tigulixostat (IBI128, XOI) in Gout Patients were Published at the 27th Asia-Pacific League of Associations for Rheumatology Congress
September 8, 2025
·
10 min read
Single-use Bioprocessing Market Size to Increase USD 128.24 Bn by 2033
According to Nova One Advisor, the global single-use bioprocessing market size was estimated at USD 28.45 billion in 2023 and it is projected to increase USD 128.24 billion by 2033 with a CAGR of 16.25% from 2024 to 2033.
April 9, 2024
·
13 min read
Tubulis Closes Upsized €128 Million Series B2 to Accelerate Clinical Development of Solid Tumor-Focused ADC Pipeline
Tubulis today announced the successful completion of an upsized and oversubscribed €128 million ($138.8 million) Series B2 financing.
March 14, 2024
·
6 min read
Genetown
Diagonal Therapeutics Launches with $128 Million in Financing to Pioneer a New Approach to Discovering and Developing Agonist Antibodies to Tackle the Underlying Causes of Severely Debilitating Diseases
Diagonal Therapeutics, a biotechnology company pioneering a new approach to discovering and developing agonist antibodies, launched with $128 million in financing.
April 3, 2024
·
4 min read
Biotechnology Instruments Market Size To Hold USD 128.4 Billion By 2032
The global biotechnology instruments market size was exhibited at USD 87.16 billion in 2022 and it is expected to hold around USD 128.4 billion by 2032, growing at a CAGR of 3.95% from 2023 to 2032.
December 19, 2023
·
7 min read
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers
Infinitopes Precision Immunomics, an integrated cancer biotech combining world leading platforms in precision antigen discovery with vaccine vectors capable of durably stimulating protective immune responses, announced the completion of a £12.8m seed funding round led by Octopus Ventures.
April 30, 2024
·
6 min read
Press Releases
Ambulatory Surgical Center Market to Reach USD 128.28 Billion by 2030, Coherent Market Insights
October 28, 2024
·
1 min read
1 of 2,601
Next
